The DOI matches its Crossref record; 132 of the 132 references it cites were found in a registry or an index.
A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Copeland, R. A. (2005) · PubMed · Cited by 1,092
Simulated Biological Fluids with Possible Application in Dissolution Testing
Marques, M. R. C., Loebenberg, R., & Almukainzi, M. (2011) · Dissolution Technologies · doi:10.14227/dt180311p15 · Cited by 1,073
Inorganic nanoparticles as carriers for efficient cellular delivery
Xu, Z. P., Zeng, Q. H., Lu, G. Q., & Yu, A. B. (2006) · Chemical Engineering Science · doi:10.1016/j.ces.2005.06.019 · Cited by 976
Expression cloning of a mammalian proton-coupled oligopeptide transporter
Fei, Y.-J., Kanai, Y., Nussberger, S., Ganapathy, V., Leibach, F. H., Romero, M. F., Singh, S. K., Boron, W. F., & Hediger, M. A. (1994) · Nature · doi:10.1038/368563a0 · Cited by 891
Novel applications of liposomes
Lasic, D. (1998) · Trends in Biotechnology · doi:10.1016/s0167-7799(98)01220-7 · Cited by 867
Pharmaceutical applications of chitosan
Dodane, V., & Vilivalam, V. D. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00059-5 · Cited by 663
Strategies to improve plasma half life time of peptide and protein drugs
Werle, M., & Bernkop-Schnürch, A. (2006) · Amino Acids · doi:10.1007/s00726-005-0289-3 · Cited by 660
FDA-approved poly(ethylene glycol)–protein conjugate drugs
Alconcel, S. N. S., Baas, A. S., & Maynard, H. D. (2011) · Polymer Chemistry · doi:10.1039/c1py00034a · Cited by 643
Physiology of the gastrointestinal tract
Dworken, H. J. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)91044-4 · Cited by 643
Stimuli-responsive polymers and their applications in drug delivery
Bawa, P., Pillay, V., Choonara, Y. E., & du Toit, L. C. (2009) · Biomedical Materials · doi:10.1088/1748-6041/4/2/022001 · Cited by 641
Self-citationIn situ gelling hydrogels for pharmaceutical and biomedical applications
Van Tomme, S. R., Storm, G., & Hennink, W. E. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.057 · Cited by 626
Alginate/Chitosan Nanoparticles are Effective for Oral Insulin Delivery
Sarmento, B., Ribeiro, A., Veiga, F., Sampaio, P., Neufeld, R., & Ferreira, D. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9367-4 · Cited by 617
Chien, Y. (1991) · CRC Press eBooks · doi:10.1201/9780367805456 · Cited by 561
Challenges for the oral delivery of macromolecules
Goldberg, M., & Gomez-Orellana, I. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1067 · Cited by 544
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540
Screening for human ADME/Tox drug properties in drug discovery
Li, A. P. (2001) · Drug Discovery Today · doi:10.1016/s1359-6446(01)01712-3 · Cited by 536
Dynamics of adherens junctions in epithelial establishment, maintenance, and remodeling
Baum, B., & Georgiou, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009141 · Cited by 509
Oral Delivery of Peptide Drugs: Barriers and Developments
Hamman, J. H., Enslin, G. M., & Kotz??, A. F. (2005) · BioDrugs · doi:10.2165/00063030-200519030-00003 · Cited by 499
A New Approach to the Oral Administration of Insulin and Other Peptide Drugs
Saffran, M., Kumar, G. S., Savariar, C., Burnham, J. C., Williams, F., & Neckers, D. C. (1986) · Science · doi:10.1126/science.3526553 · Cited by 469
Comprehensive medicinal chemistry II
Taylor, J. B. (2007) · Cited by 468
Yin, L., Ding, J., He, C., Cui, L., Tang, C., & Yin, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.06.055 · Cited by 447
Chitosan and its derivatives as intestinal absorption enhancers
Thanou, M., Verhoef, J. C., & Junginger, H. E. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00180-6 · Cited by 430
Protein purification: Principles and practice
Jakoby, W. B. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90759-5 · Cited by 418
Martins, S., Sarmento, B. F. C. C., Ferreira, D., & Souto, E. B. (2007) · PubMed Central · Cited by 399
Transdermal delivery of desmopressin using a coated microneedle array patch system
Cormier, M., Johnson, B. L., Ameri, M., Nyam, K., LIBIRAN, L., Zhang, D. D., & Daddona, P. E. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.003 · Cited by 388
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Polysaccharides for Colon Targeted Drug Delivery
Chourasia, M. K., & Jain, S. K. (2004) · Drug Delivery · doi:10.1080/10717540490280778 · Cited by 349
Camenisch, G., Alsenz, J., van de Waterbeemd, H., & Folkers, G. (1998) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(97)10019-7 · Cited by 347
Therapeutic application of peptides and proteins: parenteral forever?
Antosova, Z., Mackova, M., Kral, V., & Macek, T. (2009) · Trends in Biotechnology · doi:10.1016/j.tibtech.2009.07.009 · Cited by 324
Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., & Muranishi, S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018968611962 · Cited by 320
Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery
MAE, M., & LANGEL, U. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.004 · Cited by 317
Absorption Enhancers: Applications and Advances
Aungst, B. J. (2012) · The AAPS Journal · doi:10.1208/s12248-011-9307-4 · Cited by 309
Nano- and microparticles for the delivery of polypeptides and proteins
Couvreur, P., & Puisieux, F. (1993) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(93)90046-7 · Cited by 281
Oral protein delivery: Current status and future prospect
Park, K., Kwon, I. C., & Park, K. (2011) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.002 · Cited by 266
THE TIGHT JUNCTION: Morphology to Molecules
Stevenson, B. R., & Keon, B. H. (1998) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.14.1.89 · Cited by 256
Lung Biology in Health and Disease
(2010) · Lung biology in health and disease · doi:10.1201/ihclubihedis · Cited by 256
Constantinides, P. P., Scalart, J.-P., Lancaster, C., Marcello, J., Marks, G., Ellens, H., & Smith, P. L. (1994) · Pharmaceutical Research · doi:10.1023/a:1018927402875 · Cited by 253
Chitosan and its derivatives: potential excipients for peroral peptide delivery systems
Bernkop-Schnürch, A. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00365-8 · Cited by 250
Structural and functional diversity of cadherin at the adherens junction
Oda, H., & Takeichi, M. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201008173 · Cited by 238
Potocky, T. B., Menon, A. K., & Gellman, S. H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308719200 · Cited by 237
Recent Advances in Protein and Peptide Drug Delivery Systems
Kumar Malik, D., Baboota, S., Ahuja, A., Hasan, S., & Ali, J. (2007) · Current Drug Delivery · doi:10.2174/156720107780362339 · Cited by 216
Commercial challenges of protein drug delivery
Brown, L. R. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.1.29 · Cited by 208
Cell-penetrating peptides for drug delivery across membrane barriers
Foged, C., & Nielsen, H. M. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.1.105 · Cited by 205
Oral delivery of therapeutic protein/peptide for diabetes – Future perspectives
Rekha, M. R., & Sharma, C. P. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.03.056 · Cited by 182
Donovan, M. D., Flynn, G. L., & Amidon, G. L. (1990) · Pharmaceutical Research · doi:10.1023/a:1015921101465 · Cited by 178
Usefulness of cell-penetrating peptides to improve intestinal insulin absorption
Kamei, N., Morishita, M., Eda, Y., Ida, N., Nishio, R., & Takayama, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.08.001 · Cited by 177
Devices based on intelligent biopolymers for oral protein delivery
Peppas, N. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.03.001 · Cited by 174
Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery
Massodi, I., Bidwell, G. L., & Raucher, D. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.007 · Cited by 173
A novel approach using functional peptides for efficient intestinal absorption of insulin
Morishita, M., Kamei, N., Ehara, J., Isowa, K., & Takayama, K. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.12.022 · Cited by 165
Grover, G. N., & Maynard, H. D. (2010) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2010.10.008 · Cited by 164
Shakweh, M., Besnard, M., Nicolas, V., & Fattal, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2005.04.006 · Cited by 161
Protein drug oral delivery: The recent progress
Lee, H. J. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976925 · Cited by 161
Flux Measurements across Caco-2 Monolayers May Predict Transport in Human Large Intestinal Tissue
Rubas, W., Cromwell, M. E. M., Shahrokh, Z., Villagran, J., Nguyen, T.-N., Wellton, M., Nguyen, T.-H., & Mrsny, R. J. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950267+ · Cited by 160
Tuvia, S., Atsmon, J., Teichman, S. L., Katz, S., Salama, P., Pelled, D., Landau, I., Karmeli, I., Bidlingmaier, M., Strasburger, C. J., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1179 · Cited by 160
Systemic delivery of therapeutic peptides and proteins
Banga, A. K., & CHIEN, Y. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90246-3 · Cited by 156
Bai, J. P. F., & Amidon, G. L. (1992) · Pharmaceutical Research · doi:10.1023/a:1015885823793 · Cited by 155
Binkley, N., Bolognese, M., Sidorowicz-Bialynicka, A., Vally, T., Trout, R., Miller, C., Buben, C. E., Gilligan, J. P., Krause, D. S., & for the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) Investigators (2012) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.1602 · Cited by 149
Reis, C. P., Ribeiro, A. J., Houng, S., et al. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.12.007 · Cited by 149
Sakai, M., Imai, T., Ohtake, H., Azuma, H., & Otagiri, M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960529n · Cited by 149
Controlled Delivery of Peptides and Proteins
Değim, İ. T., & Çelebi, N. (2006) · Current Pharmaceutical Design · doi:10.2174/138161207779313795 · Cited by 147
Silica nanoparticle coated liposomes: A new type of hybrid nanocapsule for proteins
Mohanraj, V. J., Barnes, T. J., & Prestidge, C. A. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.03.061 · Cited by 143
Okada, H., Yamazaki, I., Ogawa, Y., Hirai, S., Yashiki, T., & Mima, H. (1982) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600711214 · Cited by 141
Inhalation Delivery of Therapeutic Peptides and Proteins
Adjei, A. L., & Gupta, P. (1997) · doi:10.1201/9781420001242 · Cited by 136
Leonard, T. W., Lynch, J. J., McKenna, M. J., & Brayden, D. J. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.685 · Cited by 135
Zhou, X. H. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90071-x · Cited by 128
Enhanced Intestinal Absorption of Daidzein by Borneol/Menthol Eutectic Mixture and Microemulsion
Shen, Q., Li, X., Li, W., & Zhao, X. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9672-4 · Cited by 119
Noninvasive routes of proteins and peptides drug delivery.
jitendra, Sharma, P. K., Bansal, S., & Banik, A. (2011) · PubMed Central · doi:10.4103/0250-474x.95608 · Cited by 118
Friedman, D. I., & Amidon, G. L. (1989) · Pharmaceutical Research · doi:10.1023/a:1015978420797 · Cited by 116
Protein delivery for retinal diseases: From basic considerations to clinical applications
Sanharawi, M. E., Kowalczuk, L., Touchard, E., Omri, S., de Kozak, Y., & Béhar‐Cohen, F. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.04.001 · Cited by 116
Controlled delivery of an LHRH analogue from biodegradable injectable microspheres
Sanders, L. M., McRae, G. I., Vitale, K. M., & Kell, B. A. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90044-6 · Cited by 113
Targeted enteral delivery of insulin to rats
Touítou, E., & Rubinstein, A. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90069-4 · Cited by 112
Fujii, S., Yokoyama, T., Ikegaya, K., Sato, F., & Yokoo, N. (1985) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1985.tb03064.x · Cited by 111
Ménard, S., Lebreton, C., Schümann, M., Matysiak‐Budnik, T., Dugave, C., Bouhnik, Y., Malamut, G., Cellier, C., Allez, M., Crenn, P., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.10.019 · Cited by 107
Protease inhibitors and penetration enhancers as approaches to modify peptide absorption
Lee, V. H. L. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90011-h · Cited by 107
Overcoming poor permeability: translating permeation enhancers for oral peptide delivery
Maher, S., & Brayden, D. J. (2011) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2011.11.006 · Cited by 107
Mechanistic Studies on Surfactant-Induced Membrane Permeability Enhancement
Xia, W. J., & Önyüksel, H. (2000) · Pharmaceutical Research · doi:10.1023/a:1007581202873 · Cited by 99
Eldor, R., Arbit, E., Corcos, A., & Kidron, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059524 · Cited by 98
Time-controlled oral delivery systems for colon targeting
Gazzaniga, A., Maroni, A., Sangalli, M. E., & Zema, L. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.5.583 · Cited by 95
Toorisaka, E. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00674-9 · Cited by 92
Ichikawa, H., & Peppas, N. A. (2003) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.10128 · Cited by 91
Models to Predict Intestinal Absorption of Therapeutic Peptides and Proteins
Antunes, F., Andrade, F., Ferreira, D., Nielsen, H. M., & Sarmento, B. F. C. C. (2012) · Current Drug Metabolism · doi:10.2174/138920013804545160 · Cited by 89
Models to Predict Intestinal Absorption of Therapeutic Peptides and Proteins
Antunes, F., Andrade, F., Ferreira, D., Nielsen, H. M., & Sarmento, B. F. C. C. (2012) · Current Drug Metabolism · doi:10.2174/1389200211309010004 · Cited by 87
Oral Chronotopic Drug Delivery Systems: Achievement of Time and/or Site Specificity.
Gazzaniga, A., Sangalli, M. E., & Giordano, F. (1994) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 87
Sinko, P. J., & Amidon, G. L. (1988) · Pharmaceutical Research · doi:10.1023/a:1015974920682 · Cited by 86
Investigation of archaeosomes as carriers for oral delivery of peptides
Li, Z., Chen, J., Sun, W., & Xu, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.041 · Cited by 84
Surface Modification to Control Protein/Surface Interactions
Yuan, L., Yu, Q., Li, D., & Chen, H. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000464 · Cited by 81
Update in the CNS Response to Hypoglycemia
McCrimmon, R. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1927 · Cited by 80
Walker, R. F., Codd, E. E., Barone, F. C., Nelson, A. H., Goodwin, T., & Campbell, S. A. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90563-7 · Cited by 80
Kramer, W., Girbig, F., Gutjahr, U., Kleemann, H., Leipe, I., Urbach, H., & Wagner, A. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90043-n · Cited by 79
Hashizume, M., Douen, T., Murakami, M., Yamamoto, A., Takada, K., & Muranishi, S. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05463.x · Cited by 79
Scintigraphic Evaluation of a Novel Colon-Targeted Delivery System (CODES™) in Healthy Volunteers
Katsuma, M., Watanabe, S., Takemura, S., Sako, K., Sawada, T., Masuda, Y., Nakamura, K., Fukui, M., Connor, A. L., & Wilding, I. R. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20063 · Cited by 74
Luzio, S. D., Dunseath, G. J., Lockett, A., Broke-Smith, T. P., New, R. R. C., & Owens, D. R. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01146.x · Cited by 74
A novel per‐oral insulin formulation: proof of concept study in non‐diabetic subjects
Kidron, M., Dinh, S. M., Menachem, Y., Abbas, R., Variano, B., Goldberg, M., Arbit, E., & Bar-On, H. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01160.x · Cited by 74
A review on recent advances of enteric coating
Hussan, S. D. (2012) · IOSR Journal of Pharmacy (IOSRPHR) · doi:10.9790/3013-2610511 · Cited by 74
Peptide and protein drugs: II. Non-parenteral routes of delivery
Zhou, X. H., & Po, A. L. W. (1991) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(91)90185-q · Cited by 73
Trends in drug delivery through tissue barriers containing tight junctions
Tscheik, C., Blasig, I. E., & Winkler, L. (2013) · Tissue Barriers · doi:10.4161/tisb.24565 · Cited by 72
Colon Targeted Drug Delivery Systems -An Overview
Kumar, P., & Mishra, B. (2008) · Current Drug Delivery · doi:10.2174/156720108784911712 · Cited by 70
Self-citationPoly(Ethylene Glycol) with Reactive Endgroups: I. Modification of Proteins
Herman, S. O., Hooftman, G., & Schacht, E. H. (1995) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159501000205 · Cited by 69
Studies on lactulose formulations for colon-specific drug delivery
Katsuma, M., Watanabe, S., Kawai, H., Takemura, S., Masuda, Y., & Fukui, M. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00429-5 · Cited by 66
Smart Polymers for Controlled Delivery of Proteins and Peptides: A Review of Patents
Fogueri, L. R., & Singh, S. (2009) · Recent Patents on Drug Delivery & Formulation · doi:10.2174/187221109787158300 · Cited by 65
Karsdal, M. A., Byrjalsen, I., Riis, B. J., & Christiansen, C. (2008) · BMC Clinical Pharmacology · doi:10.1186/1472-6904-8-5 · Cited by 63
Hussain, M. A., Shenvi, A. B., Rowe, S. M., & Shefter, E. (1989) · Pharmaceutical Research · doi:10.1023/a:1015949013644 · Cited by 59
Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP)
Kahns, A. H., Buur, A., & Bundgaard, H. (1993) · Pharmaceutical Research · doi:10.1023/a:1018973029651 · Cited by 58
Targeting Receptors, Transporters and Site of Absorption to Improve Oral Drug Delivery
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Drug Target Insights · doi:10.1177/117739280700200003 · Cited by 56
Scopes, R. K. (1982) · Springer eBooks · doi:10.1007/978-1-4757-1770-9_3 · Cited by 54
Oral Delivery of Glucagon-like Peptide-1 and Analogs: Alternatives for Diabetes Control?
Araújo, F., Fonte, P., Santos, H. A., & Sarmento, B. F. C. C. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600630 · Cited by 51
Curto, M. D. D., Maroni, A., Palugan, L., Zema, L., Gazzaniga, A., & Sangalli, M. E. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22560 · Cited by 47
Oral Drug Delivery and Delivery Systems
(1991) · Drugs and the pharmaceutical sciences · doi:10.1201/b14196-4 · Cited by 47
Lipid microparticles as sustained release system for a GnRH antagonist (Antide)
Curto, M. D. D., Chicco, D., D’Antonio, M., Ciolli, V., Dannan, H., Durso, S., Neuteboom, B., Pompili, S., Schiesaro, S., & Esposito, P. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00120-2 · Cited by 46
Novel oral drug delivery gateways for biotechnology products: polypeptides and vaccines
Brayden, D. J., & O’Mahony, D. J. (1998) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(98)00075-3 · Cited by 45
Lee, S., Lee, J., Lee, D. Y., Kim, S., Lee, Y.-J., & Byun, Y. (2005) · Diabetologia · doi:10.1007/s00125-004-1658-2 · Cited by 44
Pastorelli, L., Saibeni, S., Spina, L., Signorelli, C., Celasco, G., de Franchis, R., & Vecchi, M. L. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03757.x · Cited by 44
Yang, L., Watanabe, S., Li, J., Chu, J. S., Katsuma, M., Yokohama, S., & Fix, J. A. (2003) · Pharmaceutical Research · doi:10.1023/a:1022660305931 · Cited by 42
Targeting receptors, transporters and site of absorption to improve oral drug delivery.
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Europe PMC (PubMed Central) · Cited by 42
Biophysical model approaches to mechanistic transepithelial studies of peptides
Ho, N. F. H., Day, J., Barsuhn, C. L., Burton, P. S., & Raub, T. J. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90117-c · Cited by 42
Maroni, A., Curto, M. D. D., Serratoni, M., Zema, L., Foppoli, A. A., Gazzaniga, A., & Sangalli, M. E. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.12.002 · Cited by 42
Eldor, R., Kidron, M., & Arbit, E. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01153.x · Cited by 39
A mechanistic analysis of carrier-mediated oral delivery of protein therapeutics
Stoll, B. R., Leipold, H. R., Milstein, S., & Edwards, D. A. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00144-3 · Cited by 36
The transport of an intact oligopeptide across adult mammalian jejunum
Takaori, K., Burton, J. A., & Donowitz, M. (1986) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(86)91132-0 · Cited by 36
Insight of current technologies for oral delivery of proteins and peptides
Chin, J., Mahmud, F., Kim, S. E., Park, K., & Byun, Y. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.04.005 · Cited by 32
Transport of proteins and peptides across human cultured alveolar A549 cell monolayer
Wang, Z., & Zhang, Q. (2003) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.033 · Cited by 31
Liu, Z., Wang, S., & Hu, M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-444-53242-8.00011-4 · Cited by 31
Polymeric eutectic drug delivery system
Tuntarawongsa, S., & Phaechamud, T. (2012) · Journal of Metals Materials and Minerals · Cited by 20
Intestinal absorption of peptide drugs: advances in our understanding and clinical implications.
Catnach, S. M., Fairclough, P. D., & Hammond, S. M. (1994) · Gut · doi:10.1136/gut.35.4.441 · Cited by 18
Passive Permeability and Active Transport Models for the Prediction of Oral Absorption
Artursson, P., Neuhoff, S., Matsson, P., & Tavelin, S. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00126-7 · Cited by 16
The Delivery of Drugs – Peptides and Proteins
Schiffter, H. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00338-x · Cited by 13
Cellular Kinetics of Villous Epithelial Cells and M Cells in Rabbit Small Intestine
Takeuchi, T., & Gonda, T. (2004) · Journal of Veterinary Medical Science · doi:10.1292/jvms.66.689 · Cited by 12
Transepithelial Transport of Proteins by Intestinal Epithelial Cells
Neutra, M. R., & Kraehenbühl, J.-P. (1993) · Pharmaceutical biotechnology · doi:10.1007/978-1-4615-2898-2_5 · Cited by 9
Effect of insulin concentration on bioavailability during nasal spray administration.
Valensi, P. E., Zirinis, P., Nicolas, P., Perret, G. Y., Sandre-Banon, D., & Attali, J. R. (1996) · PubMed · Cited by 8
PEGylation-Successful Approach for Therapeutic Protein Conjugation
Yang, T. (2013) · Modern Chemistry & Applications · doi:10.4172/2329-6798.1000e112 · Cited by 3
Cited by
Non-invasive delivery strategies for biologics
Anselmo, A. C., Gokarn, Y., & Mitragotri, S. (2019) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.183 · Cited by 665
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview
Zhao, J., Yang, J., & Xie, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118642 · Cited by 421
pH-Responsive carriers for oral drug delivery: Challenges and opportunities of current platforms
Liu, L., Yao, W., Rao, Y., Lu, X., & Gao, J. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1279238 · Cited by 420
“Conventionally, many drugs, especially therapeutic proteins, are administered subcutaneously, intramuscularly or intravenously since oral administration may cause low bioavailability in the GI tract (Choonara et al., 2014).”
BackgroundInfluential
Metadata
- Authors
- Choonara, B. F., Choonara, Y. E., Kumar, P., Bijukumar, D., du Toit, L. C., & Pillay, V.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 32
- Issue
- 7
- Pages
- 1269-1282
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W1985304698
- Cited by
- 311
- References
- 132
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.